Abstract
The 22q11.2 deletion syndrome (22q11.2DS) is caused by recurrent hemizygous deletions of chromosome 22q11.2. The phenotype of the syndrome is complex and varies widely among individuals. Little is known about the role of the different genes located in 22q11.2, and we hypothesized that genetic risk factors lying elsewhere in the genome might contribute to the phenotype. Here, we present the whole-genome gene expression data of 11 patients with approximately 3 Mb deletions. Apart from the hemizygous genes mapped to the 22q11.2 region, the TUBA8 and GNAZ genes, neighboring the deleted interval but in normal copy number, showed altered expression. When genes mapped to other chromosomes were considered in the gene expression analysis, a genome-wide dysregulation was observed, with increased or decreased expression levels. The enriched pathways of these genes were related to immune response, a deficiency that is frequently observed in 22q11.2DS patients. We also used the hypothesis-free weighted gene co-expression network analysis (WGCNA), which revealed the co-expression gene network modules with clear connection to mechanisms associated with 22q11.2DS such as immune response and schizophrenia. These findings, combined with the traditional gene expression profile, can be used for the identification of potential pathways and genes not previously considered to be related to the 22q11.2 deletion syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdollahi MR et al (2009) Mutation of the variant alpha-tubulin TUBA8 results in polymicrogyria with optic nerve hypoplasia. Am J Hum Genet 85:737–744. https://doi.org/10.1016/j.ajhg.2009.10.007
Bailey JA et al (2002) Human-specific duplication and mosaic transcripts: the recent paralogous structure of chromosome 22. Am J Hum Genet 70:83–100. https://doi.org/10.1086/338458
Bassett AS, Chow EW (2008) Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 10:148–157
Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, Gatzoulis MA (2005) Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 138:307–313. https://doi.org/10.1002/ajmg.a.30984
Bertini V, Azzara A, Legitimo A, Milone R, Battini R, Consolini R, Valetto A (2017) Deletion extents are not the cause of clinical variability in 22q11.2 deletion syndrome: does the interaction between DGCR8 and miRNA-CNVs play a major role? Front Genet 8:47. https://doi.org/10.3389/fgene.2017.00047
Bi W, Park SS, Shaw CJ, Withers MA, Patel PI, Lupski JR (2003) Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2. Am J Hum Genet 73:1302–1315. https://doi.org/10.1086/379979
Bittel DC, Yu S, Newkirk H, Kibiryeva N, Holt A III, Butler MG, Cooley LD (2009) Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res 124:113–120. https://doi.org/10.1159/000207515
Burn J, Goodship J (1996) Developmental genetics of the heart. Curr Opin Genet Dev 6:322–325
Chen EY et al (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14:128. https://doi.org/10.1186/1471-2105-14-128
Cramer SC, Schaefer PW, Krishnamoorthy KS (1996) Microgyria in the distribution of the middle cerebral artery in a patient with DiGeorge syndrome. J Child Neurol 11:494–497. https://doi.org/10.1177/088307389601100619
Diggle CP et al (2017) A tubulin alpha 8 mouse knockout model indicates a likely role in spermatogenesis but not in brain development. PLoS One 12:e0174264. https://doi.org/10.1371/journal.pone.0174264
Dykes IM et al (2014) HIC2 is a novel dosage-dependent regulator of cardiac development located within the distal 22q11 deletion syndrome region. Circ Res 115:23–31. https://doi.org/10.1161/CIRCRESAHA.115.303300
Edelmann L, Pandita RK, Morrow BE (1999) Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet 64:1076–1086
Fong HK, Yoshimoto KK, Eversole-Cire P, Simon MI (1988) Identification of a GTP-binding protein alpha subunit that lacks an apparent ADP-ribosylation site for pertussis toxin. Proc Natl Acad Sci USA 85:3066–3070
Gao W et al (2015) DGCR6 at the proximal part of the DiGeorge critical region is involved in conotruncal heart defects. Hum Genome Var 2:15004. https://doi.org/10.1038/hgv.2015.4
Ghazalpour A et al (2006) Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet 2:e130. https://doi.org/10.1371/journal.pgen.0020130
Gross SJ et al (2016) Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet Gynecol 47:177–183. https://doi.org/10.1002/uog.15754
Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A (2001) Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27:293–298. https://doi.org/10.1038/85855
Harewood L et al (2010) The effect of translocation-induced nuclear reorganization on gene expression. Genome Res 20:554–564. https://doi.org/10.1101/gr.103622.109
Iascone MR, Vittorini S, Sacchelli M, Spadoni I, Simi P, Giusti S (2002) Molecular characterization of 22q11 deletion in a three-generation family with maternal transmission. Am J Med Genet 108:319–321. https://doi.org/10.1002/ajmg.10268
Jalbrzikowski M et al (2015) Transcriptome profiling of peripheral blood in 22q11.2 deletion syndrome reveals functional pathways related to psychosis and autism spectrum disorder. PLoS One 10:e0132542. https://doi.org/10.1371/journal.pone.0132542
Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE (2001) Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome. J Pediatr 139:715–723. https://doi.org/10.1067/mpd.2001.118534
Jerome LA, Papaioannou VE (2001) DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286–291. https://doi.org/10.1038/85845
Kawame H et al (2001) Graves’ disease in patients with 22q11.2 deletion. J Pediatr 139:892–895. https://doi.org/10.1067/mpd.2001.119448
Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443–1452. https://doi.org/10.1016/S0140-6736(07)61601-8
Kuleshov MV et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90–W97. https://doi.org/10.1093/nar/gkw377
Lieberman-Aiden E et al (2009) Comprehensive mapping of long range interactions reveals folding principles of the human genome. Science 326:289–293. https://doi.org/10.1126/science.1181369
Lindsay EA, Baldini A (1997) A mouse gene (Dgcr6) related to the Drosophila gonadal gene is expressed in early embryogenesis and is the homolog of a human gene deleted in DiGeorge syndrome. Cytogenet Cell Genet 79:243–247. https://doi.org/10.1159/000134736
Lin M et al (2016) Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion. BMC Syst Biol 10:105. https://doi.org/10.1186/s12918-016-0366-0
Lu JH, Chung MY, Hwang B, Chien HP (2001) Monozygotic twins with chromosome 22q11 microdeletion and discordant phenotypes in cardiovascular patterning. Pediatr Cardiol 22:260–263. https://doi.org/10.1007/s002460010219
Mantripragada KK, Tapia-Paez I, Blennow E, Nilsson P, Wedell A, Dumanski JP (2004) DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets. Int J Mol Med 13:273–279
Matsuoka M, Itoh H, Kozasa T, Kaziro Y (1988) Sequence analysis of cDNA and genomic DNA for a putative pertussis toxin-insensitive guanine nucleotide-binding regulatory protein alpha subunit. Proc Natl Acad Sci USA 85:5384–5388
McDonald-McGinn DM et al (2015) 22q11.2 deletion syndrome. Nat Rev Dis Primers 1:15071. https://doi.org/10.1038/nrdp.2015.71
Merla G et al (2006) Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. Am J Hum Genet 79:332–341. https://doi.org/10.1086/506371
Merscher S et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619–629
Michel M, Schmidt MJ, Mirnics K (2012) Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol 72:1277–1287. https://doi.org/10.1002/dneu.22044
Migliavacca E et al (2015) A potential contributory role for ciliary dysfunction in the 16p11.2 600 kb BP4-BP5 pathology. Am J Hum Genet 96:784–796. https://doi.org/10.1016/j.ajhg.2015.04.002
Mlynarski EE et al (2015) Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome. Am J Hum Genet 96:753–764. https://doi.org/10.1016/j.ajhg.2015.03.007
Mlynarski EE et al (2016) Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome. Hum Genet 135:273–285. https://doi.org/10.1007/s00439-015-1623-9
Morsheimer M, Brown Whitehorn TF, Heimall J, Sullivan KE (2017) The immune deficiency of chromosome 22q11.2 deletion syndrome. Am J Med Genet A 173:2366–2372. https://doi.org/10.1002/ajmg.a.38319
Muller N, Hofschuster E, Ackenheil M, Eckstein R (1993) T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr Scand 87:66–71
Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940–945
Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ (1996) Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 153:1541–1547. https://doi.org/10.1176/ajp.153.12.1541
Pavlicek A, House R, Gentles AJ, Jurka J, Morrow BE (2005) Traffic of genetic information between segmental duplications flanking the typical 22q11.2 deletion in velo-cardio-facial syndrome/DiGeorge syndrome. Genome Res 15:1487–1495. https://doi.org/10.1101/gr.4281205
Pfuhl T et al (2005) Biochemical characterisation of the proteins encoded by the DiGeorge critical region 6 (DGCR6) genes. Hum Genet 117:70–80. https://doi.org/10.1007/s00439-005-1267-2
Phillips HM et al (2002) Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3 expressed during cardiogenesis. Genomics 79:475–478. https://doi.org/10.1006/geno.2002.6742
Prescott K, Ivins S, Hubank M, Lindsay E, Baldini A, Scambler P (2005) Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome. Hum Genet 116:486–496. https://doi.org/10.1007/s00439-005-1274-3
Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR (1996) A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 12:288–297. https://doi.org/10.1038/ng0396-288
Ripke S et al (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427. https://doi.org/10.1038/nature13595
Riquelme Medina I, Lubovac-Pilav Z (2016) Gene co-expression network analysis for identifying modules and functionally enriched pathways in type 1 Diabetes. PLoS One 11:e0156006. https://doi.org/10.1371/journal.pone.0156006
Robin NH, Shprintzen RJ (2005) Defining the clinical spectrum of deletion 22q11.2. J Pediatr 147:90–96. https://doi.org/10.1016/j.jpeds.2005.03.007
Romaniello R, Arrigoni F, Bassi MT, Borgatti R (2015) Mutations in alpha- and beta-tubulin encoding genes: implications in brain malformations. Brain Dev 37:273–280. https://doi.org/10.1016/j.braindev.2014.06.002
Shaikh TH et al (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9:489–501
Taddei I, Morishima M, Huynh T, Lindsay EA (2001) Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes. Proc Natl Acad Sci USA 98:11428–11431. https://doi.org/10.1073/pnas.201127298
Urban AE et al (2006) High-resolution mapping of DNA copy alterations in human chromosome 22 using high-density tiling oligonucleotide arrays. Proc Natl Acad Sci USA 103:4534–4539. https://doi.org/10.1073/pnas.0511340103
van Beveren NJ et al (2012) Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome. PLoS One 7:e33473. https://doi.org/10.1371/journal.pone.0033473
Vitelli F, Morishima M, Taddei I, Lindsay EA, Baldini A (2002) Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet 11:915–922
Williams NM (2011) Molecular mechanisms in 22q11 deletion syndrome. Schizophr Bull 37:882–889. https://doi.org/10.1093/schbul/sbr095
Yamagishi H et al (1998) Phenotypic discordance in monozygotic twins with 22q11.2 deletion. Am J Med Genet 78:319–321
Ying X et al (2016) Novel protective role for ubiquitin-specific protease 18 in pathological cardiac remodeling. Hypertension 68:1160–1170. https://doi.org/10.1161/HYPERTENSIONAHA.116.07562
Yovel G, Sirota P, Mazeh D, Shakhar G, Rosenne E, Ben-Eliyahu S (2000) Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav Immun 14:153–169. https://doi.org/10.1006/brbi.1999.0574
Zackai EH, Emanuel BS (1980) Site specific reciprocal translocation, t(11;22)(q23;q11) in several unrelated families with 3:1 meiotic disjunction. Am J Med Genet 7:507–521. https://doi.org/10.1002/ajmg.1320070412
Zhang X et al (2018) Local and global chromatin interactions are altered by large genomic deletions associated with human brain development. Nat Commun 9(1):5356. https://doi.org/10.1038/s41467-018-07766-x
Acknowledgements
This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant Nos. 2014/11572-8, 2014/26768-5).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dantas, A.G., Santoro, M.L., Nunes, N. et al. Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome. Hum Genet 138, 93–103 (2019). https://doi.org/10.1007/s00439-018-01967-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-018-01967-6